The higher levels of LAMTOR1 and LAMTOR5 indicate an upregulation of mTORC1 in PBMCs from ME/CFS patients [68]. The gene discussed is LAMTOR1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.